Can children of the Sputnik V vaccine recipients become symptomatic?

Sputnik V is one of the most promising vaccines, utilizing an Adenovirus vector to cause immunity against SARS-CoV-2. Concerns existed against Adenovirus infection with this vaccine, although seemed to be a rare event. In this study, we observed that 15/18 (83%) of the children of the Sputnik V reci...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehraeen, Esmaeil, SeyedAlinaghi, SeyedAhmad, Karimi, Amirali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290368/
https://www.ncbi.nlm.nih.gov/pubmed/34241575
http://dx.doi.org/10.1080/21645515.2021.1933689
_version_ 1783724478572789760
author Mehraeen, Esmaeil
SeyedAlinaghi, SeyedAhmad
Karimi, Amirali
author_facet Mehraeen, Esmaeil
SeyedAlinaghi, SeyedAhmad
Karimi, Amirali
author_sort Mehraeen, Esmaeil
collection PubMed
description Sputnik V is one of the most promising vaccines, utilizing an Adenovirus vector to cause immunity against SARS-CoV-2. Concerns existed against Adenovirus infection with this vaccine, although seemed to be a rare event. In this study, we observed that 15/18 (83%) of the children of the Sputnik V recipients became symptomatic and developed transient fever and chills for 1–2 days starting after 2–5 days following the vaccination of their parents that can be related to an Adenovirus infection. To our knowledge, this is the first study reporting such symptoms in the children of Sputnik V recipients, and the results should be validated by larger studies.
format Online
Article
Text
id pubmed-8290368
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-82903682021-07-21 Can children of the Sputnik V vaccine recipients become symptomatic? Mehraeen, Esmaeil SeyedAlinaghi, SeyedAhmad Karimi, Amirali Hum Vaccin Immunother Letters Sputnik V is one of the most promising vaccines, utilizing an Adenovirus vector to cause immunity against SARS-CoV-2. Concerns existed against Adenovirus infection with this vaccine, although seemed to be a rare event. In this study, we observed that 15/18 (83%) of the children of the Sputnik V recipients became symptomatic and developed transient fever and chills for 1–2 days starting after 2–5 days following the vaccination of their parents that can be related to an Adenovirus infection. To our knowledge, this is the first study reporting such symptoms in the children of Sputnik V recipients, and the results should be validated by larger studies. Taylor & Francis 2021-07-09 /pmc/articles/PMC8290368/ /pubmed/34241575 http://dx.doi.org/10.1080/21645515.2021.1933689 Text en © 2021 Taylor & Francis Group, LLC
spellingShingle Letters
Mehraeen, Esmaeil
SeyedAlinaghi, SeyedAhmad
Karimi, Amirali
Can children of the Sputnik V vaccine recipients become symptomatic?
title Can children of the Sputnik V vaccine recipients become symptomatic?
title_full Can children of the Sputnik V vaccine recipients become symptomatic?
title_fullStr Can children of the Sputnik V vaccine recipients become symptomatic?
title_full_unstemmed Can children of the Sputnik V vaccine recipients become symptomatic?
title_short Can children of the Sputnik V vaccine recipients become symptomatic?
title_sort can children of the sputnik v vaccine recipients become symptomatic?
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290368/
https://www.ncbi.nlm.nih.gov/pubmed/34241575
http://dx.doi.org/10.1080/21645515.2021.1933689
work_keys_str_mv AT mehraeenesmaeil canchildrenofthesputnikvvaccinerecipientsbecomesymptomatic
AT seyedalinaghiseyedahmad canchildrenofthesputnikvvaccinerecipientsbecomesymptomatic
AT karimiamirali canchildrenofthesputnikvvaccinerecipientsbecomesymptomatic

Ejemplares similares